Sale disclosed
Salvatore Privitera
Chief Technical Officer
Common Stock
- Reported value
- $271.14K
- Reported price
- $60.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
AtriCure, Inc.
Last 30 daysNo qualifying insider buying. Sales: $760.35K by 2 insiders.
Showing the first 6 of 12 trades on this page.
Chief Technical Officer
Common Stock
Director
Common Stock
Chief Technical Officer
Common Stock
Chief Technical Officer
Common Stock
Chief Legal Officer
Common Stock
Director
Common Stock
Director
Common Stock
Chief Scientific Officer
Common Stock
Director
Common Stock
Chief Mktg & Strategy Officer
Common Stock
Director
Common Stock
Chief Scientific Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Technical Officer | Common StockSale10b5-1 | 4,519$60.00 / share | $271.14K | Sep 23Filed Sep 24 · 1d later | SEC filing |
| Director | Common StockSale | 5,313$54.22 / share | $288.07K | Sep 11Filed Sep 14 · 3d later | SEC filing |
| Chief Technical Officer | Common StockSale10b5-1 | 3,657$55.00 / share | $201.14K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| Chief Technical Officer | Common StockSale10b5-1 | 7,763$52.50 / share | $407.56K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale | 9,370$48.89 / share | $458.1K | Aug 24Filed Aug 26 · 2d later | SEC filing |
| Director | Common StockSale | 3,564$38.80 / share | $138.28K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Director | Common StockSale | 3,500$38.42 / share | $134.47K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Chief Scientific Officer | Common StockSale | 6,000$38.88 / share | $233.28K | Jul 28Filed Jul 30 · 2d later | SEC filing |
| Director | Common StockSale | 25,000$37.84 / share | $946K | Jul 28Filed Jul 30 · 2d later | SEC filing |
| Chief Mktg & Strategy Officer | Common StockSale | 6,182$38.80 / share | $239.86K | Jul 29Filed Jul 30 · 1d later | SEC filing |
| Director | Common StockSale | 3,000$28.65 / share | $85.95K | May 20Filed May 22 · 2d later | SEC filing |
| Chief Scientific Officer | Common StockSale | 5,000$28.13 / share | $140.65K | May 15Filed May 18 · 3d later | SEC filing |
AtriCure, Inc. - Common Stock (ATRC) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberAtriCure, Inc. - Common Stock (ATRC) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.